Literature DB >> 3664920

Postoperative neuroleptic malignant syndrome. A case report.

P Patel1, G Bristow.   

Abstract

A case of postoperative neuroleptic malignant syndrome is presented. A healthy 23-year-old male underwent a shoulder repair under uneventful fentanyl, halothane, nitrous oxide and oxygen anaesthesia. He received droperidol 5 mg IV and metoclopramide 10 mg IV intraoperatively to prevent postoperative nausea. Postoperatively, the patient developed autonomic instability, fever and generalized muscle rigidity. His level of consciousness was depressed. These findings were consistent with the diagnosis of neuroleptic malignant syndrome. The supportive treatment of the patient included active cooling measures, muscle relaxation and mechanical ventilation. The ability of anti-dopaminergic agents, including metoclopramide and droperidol, to precipitate the neuroleptic malignant syndrome is discussed. Treatment of the neuroleptic malignant syndrome is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664920     DOI: 10.1007/BF03014361

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  9 in total

Review 1.  Current concepts. Neuroleptic malignant syndrome.

Authors:  B H Guzé; L R Baxter
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

2.  Postoperative neurologic dysfunction associated with preoperative administration of metoclopramide.

Authors:  M S Scheller; K L Sears
Journal:  Anesth Analg       Date:  1987-03       Impact factor: 5.108

3.  Fever associated with metoclopramide-induced dystonia.

Authors:  I Wandless; J G Evans; M Jackson
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

Review 4.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

Review 5.  The neuroleptic malignant syndrome--a review.

Authors:  W R Gibb; A J Lees
Journal:  Q J Med       Date:  1985-08

6.  The neuroleptic malignant syndrome.

Authors:  R A Smego; D T Durack
Journal:  Arch Intern Med       Date:  1982-06

Review 7.  Neuroleptic malignant syndrome.

Authors:  R J Abbott; L A Loizou
Journal:  Br J Psychiatry       Date:  1986-01       Impact factor: 9.319

8.  Coma following ECT and intravenous droperidol: case report.

Authors:  J Y Koo; C P Chien
Journal:  J Clin Psychiatry       Date:  1986-02       Impact factor: 4.384

9.  Adverse neurologic effects of metoclopramide.

Authors:  J D Grimes; M N Hassan; D N Preston
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

  9 in total
  5 in total

1.  Postoperative neuroleptic malignant syndrome.

Authors:  M J Douglas
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

2.  Sudden discontinuation and reinstitution of olanzapine-associated atypical neuroleptic malignant syndrome in a patient undergoing lung surgery.

Authors:  Zhiyong Zhao; Hua Zhang; Shaohua Wang; Xiaofeng Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  "Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours.

Authors:  Naoto Mizumura; Masato Uematsu; Aya Ito; Satoshi Okumura; Hiromitsu Maehira; Masao Ogawa; Masayasu Kawasaki
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

4.  Postoperative neuroleptic malignant syndrome-like symptoms improved with intravenous diazepam: a case report.

Authors:  Shun Kishimoto; Kumi Nakamura; Toshiyuki Arai; Ogino Yukimasa; Norihiko Fukami
Journal:  J Anesth       Date:  2013-04-04       Impact factor: 2.078

5.  Neuroleptic malignant syndrome in a young adult female at the university of Benin Teaching Hospital: a case report.

Authors:  Peter I Agbonrofo; John E Osakue
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.